Home Kurve Therapeutics

Kurve Therapeutics

In operation
-
Developer of Neurodegenerative Disease Therapeutics
Basic
Enterprise Profile

Basic Information

Kurve Therapeutics is a medical technology and drug formulation company that develops Controlled Particle Dispersion® (CPD) intranasal drug delivery technology. This technology aims to advance the treatment of neurodegenerative diseases, including enabling drugs to cross the blood-brain barrier for treatment with complex molecules such as monoclonal antibodies and peptides.
Kurve Therapeutics, Inc.
Washington,United States of America
less than 15 people
January 01, 2001
info@kurvetx.com

Enterprise Profile

Industrial Sector
New Drug Development
Concept
# Brain Sciences Therapeutic Products
Application Scenarios
Innovative Drugs